Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 28/07/2026 5-day change 1st Jan Change
15.72 CNY -0.38% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -2.78% -16.25%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.14B 1.05B 925M 862M 793M 1.49B 101B 1.51B 10.22B 4B 49.96B 3.96B 3.87B 173B P/E 2026 *
16.1x
P/E 2027 * 13.9x
Enterprise Value 7.66B 1.13B 993M 925M 850M 1.59B 108B 1.62B 10.97B 4.29B 53.6B 4.25B 4.16B 185B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.75x
Free-Float
51.96%
Yield 2026 *
1.91%
Yield 2027 * 3.07%
06-10 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-27 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
30/04/25 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day-0.38%
1 week-2.78%
Current month+8.94%
1 month+9.32%
3 months-11.73%
6 months-23.09%
Current year-16.25%
1 week 15.43
Extreme 15.43
16.35
1 month 13.91
Extreme 13.91
16.95
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 37 15/12/2025
Director/Board Member 53 25/12/2019
Date Insider Type Main position Quantity % Market Cap.
16/06/26 Buy

Chief Executive Officer

500,000 0.1535%
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.78%-28.28%-15.94% 1.06B
+1.38%+3.49%-48.27%-58.94% 32.25B
+1.28%+1.51%+77.40%+115.72% 12.69B
+0.74%+1.74%-19.05%+0.37% 3.7B
+2.52%+1.02%-5.08%+18.52% 3.21B
+2.93%+4.00%-3.20%+30.48% 1.86B
-0.36%-2.62%+27.02%+11.18% 1.8B
+3.32%+7.74%+26.14%+153.86% 1.43B
+0.28%+1.39%-7.85%-22.39% 960M
+0.95%-4.33%-18.78%-47.33% 956M
Average +1.26%+1.11%+0.00%+18.56% 5.99B
Weighted average by Cap. +1.39%+1.05%-10.62%-2.64%

Financials

2026 *2027 *
Net sales 3.77B 557M 489M 455M 418M 784M 53.18B 798M 5.4B 2.11B 26.37B 2.09B 2.04B 91.12B 4.26B 629M 552M 514M 473M 887M 60.12B 902M 6.1B 2.39B 29.81B 2.36B 2.31B 103B
Net income 441M 65.16M 57.18M 53.25M 48.98M 91.81M 6.23B 93.39M 632M 247M 3.09B 245M 239M 10.67B 527M 77.92M 68.38M 63.68M 58.57M 110M 7.44B 112M 755M 296M 3.69B 293M 286M 12.76B
Net Debt 519M 76.73M 67.34M 62.7M 57.67M 108M 7.33B 110M 744M 291M 3.64B 288M 282M 12.56B 337M 49.78M 43.69M 40.69M 37.42M 70.15M 4.76B 71.35M 483M 189M 2.36B 187M 183M 8.15B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
28/07/26 CN¥15.72 -0.38% 2,046,300
27/07/26 CN¥15.78 +1.61% 2,792,657
24/07/26 CN¥15.53 -3.42% 2,900,400
23/07/26 CN¥16.08 +1.01% 3,645,545
22/07/26 CN¥15.92 -1.79% 6,033,823
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.72CNY
Average target price
20.41CNY
Spread / Average Target
+29.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock